ESRP1 binding to the PHGDH 5′-UTR enhances transcript stability in therapy-resistant ER+ breast cancer [40, 41], whereas eIF3i recognizes m6A marks to selectively promote PHGDH translation in colorectal cancer [42]. Here, PHGDH is linked to breast carcinoma.